ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. | Canada Hyperbarics Skip to main content
Retrospective Study International journal of radiation oncology, biology, physics 2002

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.

Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS — International journal of radiation oncology, biology, physics, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers screened 46 female breast cancer patients for ATM gene mutations to determine if these mutations correlated with severe radiotherapy-induced effects.

What They Found

They identified nine ATM mutations, eight of which were novel, in six of the 46 patients. The study found a significant correlation between the presence of ATM mutations and an increase in radiation-induced late effects.

What This Means for Canadian Patients

Canadian patients with breast cancer who are candidates for radiotherapy might benefit from genetic screening for ATM mutations to assess their risk of severe side effects. This information could help personalize treatment plans and potentially mitigate adverse radiation responses.

Canadian Relevance

This study was not conducted in Canada and does not have a direct Canadian connection.

Study Limitations

A limitation of this study is its relatively small sample size of 46 patients, which may limit the generalizability of the findings.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Radiation Injury
Source Pubmed
PubMed ID 11849780
Year Published 2002
Journal International journal of radiation oncology, biology, physics
MeSH Terms Adult; Aged; Aged, 80 and over; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Cycle Proteins; Chromatography, High Pressure Liquid; DNA-Binding Proteins; Female; Humans; Middle Aged; Mutation; Neoplasm Staging; Protein Serine-Threonine Kinases; Radiation Tolerance

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology